Literature DB >> 428417

Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.

D G Benditt, E L Pritchett, A G Wallace, J J Gallagher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 428417

Source DB:  PubMed          Journal:  Eur J Cardiol        ISSN： 0301-4711


× No keyword cloud information.
  5 in total

Review 1.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 2.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

3.  Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.

Authors:  M Manz; G Steinbeck; J Nitsch; B Lüderitz
Journal:  Br Heart J       Date:  1983-03

4.  [Value and risk of programmed ventricular stimulation in patients with chronic recurrent ventricular tachycardia (author's transl)].

Authors:  G Steinbeck; M Manz; B Lüderitz
Journal:  Klin Wochenschr       Date:  1981-02-02

Review 5.  Reliability of antiarrhythmic drug plasma concentration monitoring.

Authors:  F Follath; U Ganzinger; E Schuetz
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.